Literature DB >> 6305004

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase.

B H Robertson, D O Morgan, D M Moore, M J Grubman, J Card, T Fischer, G Weddell, D Dowbenko, D Yansura.   

Abstract

Foot-and-mouth disease virus (FMDV) RNA polymerase was purified from the polyethylene glycol (PEG)-treated supernatant of infected cell media by a combination of ion-exchange chromatography, membrane molecular filtration, and affinity chromatography. The purified RNA polymerase which migrated as a single band of 56,000 molecular weight on a polyacrylamide gel was subjected to automated Edman degradation and the sequence of the first 30 amino acid residues established. On the basis of previous evidence, which indicated that the RNA polymerase was the most 3'-translated polypeptide, plasmids containing cDNA mapping at the 3' end of the genome were characterized by restriction enzyme analysis and nucleotide sequencing. These investigations definitively established the derived amino acid sequence by confirmation of 28 of the amino terminal residues determined by amino acid sequence analysis; the location of the FMDV RNA polymerase coding region at the extreme 3' end of the genome, 96 nucleotides from the poly(A) tail; and the N-terminal cleavage point of the RNA polymerase from its precursor P100 was found to be a glutamic acid-glycine bond.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305004     DOI: 10.1016/s0042-6822(83)80017-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus.

Authors:  B E Clarke; A L Brown; K M Currey; S E Newton; D J Rowlands; A R Carroll
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

3.  The effects of the codon usage and translation speed on protein folding of 3D(pol) of foot-and-mouth disease virus.

Authors:  Xiao-Xia Ma; Yu-Ping Feng; Jun-Lin Liu; Bing Ma; Li Chen; Yong-Qing Zhao; Peng-Hui Guo; Jun-Zhen Guo; Zhong-Ren Ma; Jie Zhang
Journal:  Vet Res Commun       Date:  2013-05-29       Impact factor: 2.459

4.  Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study.

Authors:  C Ye; J Luo; X Wang; J Xi; Y Pan; J Chen; X Yang; G Li; Q Sun; J Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-19       Impact factor: 3.267

5.  Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins.

Authors:  K Strebel; E Beck; K Strohmaier; H Schaller
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus.

Authors:  A R Carroll; D J Rowlands; B E Clarke
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

7.  Effect of salts and other agents on foot-and-mouth disease virus poly (U) polymerase activity.

Authors:  J Polatnick
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Biochemical map of polypeptides specified by foot-and-mouth disease virus.

Authors:  M J Grubman; B H Robertson; D O Morgan; D M Moore; D Dowbenko
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region.

Authors:  A C Palmenberg; E M Kirby; M R Janda; N L Drake; G M Duke; K F Potratz; M S Collett
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

10.  Nucleotide sequence and genome organization of foot-and-mouth disease virus.

Authors:  S Forss; K Strebel; E Beck; H Schaller
Journal:  Nucleic Acids Res       Date:  1984-08-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.